Stugeron Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Cinnarizine

Indications/Uses

Maintenance therapy for symptoms of labyrinthine disorders. Prophylaxis of motion sickness.

Click to view Stugeron detailed prescribing information

Dosage/Direction for Use

Adult Balance disorders 1 tab tds. Motion sickness Adult & adolescent ≥13 yr 1 tab at least ½ hr before traveling, repeated every 6 hr. Childn 6-12 yr ½ adult dose.

Click to view Stugeron detailed prescribing information

Overdosage

View Stugeron overdosage for action to be taken in the event of an overdose.

Administration

Should be taken with food.

Contraindications

Hypersensitivity.

Click to view Stugeron detailed prescribing information

Special Precautions

Parkinson's disease. May cause epigastric distress. Concomitant use w/ alcohol, CNS depressants or TCAs. May affect ability to drive & use machines. Pregnancy. Not to be used during lactation.

Click to view Stugeron detailed prescribing information

Use In Pregnancy & Lactation

Click to view Stugeron detailed prescribing information

Adverse Reactions

Somnolence; nausea; increased wt.

Click to view Stugeron detailed prescribing information

Drug Interactions

Potentiated sedative effects w/ alcohol or CNS depressants or TCAs. May prevent +ve reactions to dermal reactivity indicators if used up to 4 days prior to skin testing.

Click to view Stugeron detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Stugeron detailed prescribing information

Storage

View Stugeron storage conditions for details to ensure optimal shelf-life.

Description

View Stugeron description for details of the chemical structure and excipients (inactive components).

Action

View Stugeron mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Peripheral Vasodilators & Cerebral Activators / Antivertigo Drugs

ATC Classification

N07CA02 - cinnarizine ; Belongs to the class of antivertigo preparations.

Regulatory Classification

Presentation/Packing

Form

Stugeron tab 25 mg

Packing/Price

50's

Stugeron

cinnarizine

Manufacturer:

Janssen

Distributor:

Zuellig Pharma